This investigation was performed to evaluate the potential with the CPPs with tumor-targeting Attributes to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic system for CXCR4+ HCC cells. T22 was picked given that the nanocarrier https://https143316com76429.bloggactivo.com/30883149/the-definitive-guide-to-https-1433778-com